{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:16:01Z","timestamp":1775229361398,"version":"3.50.1"},"reference-count":0,"publisher":"Therapeutic Guidelines Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aust Prescr"],"DOI":"10.18773\/austprescr.2025.006","type":"journal-article","created":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T19:35:31Z","timestamp":1739734531000},"page":"27-28","source":"Crossref","is-referenced-by-count":2,"title":["New Drug: Mavacamten for symptomatic obstructive hypertrophic cardiomyopathy"],"prefix":"10.18773","volume":"48","member":"39051","published-online":{"date-parts":[[2025,2,18]]},"container-title":["Australian Prescriber"],"original-title":[],"link":[{"URL":"https:\/\/australianprescriber.tg.org.au\/articles\/mavacamten-for-symptomatic-obstructive-hypertrophic-cardiomyopathy.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T14:37:31Z","timestamp":1775227051000},"score":1,"resource":{"primary":{"URL":"https:\/\/australianprescriber.tg.org.au\/articles\/mavacamten-for-symptomatic-obstructive-hypertrophic-cardiomyopathy.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,18]]}},"URL":"https:\/\/doi.org\/10.18773\/austprescr.2025.006","relation":{},"ISSN":["1839-3942"],"issn-type":[{"value":"1839-3942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]}}}